Health insurer stocks faced a significant downturn in after-hours trading on Monday following a report detailing the Trump administration’s plans for Medicare insurer rates in 2027. According to sources cited by The Wall Street Journal, the administration is expected to propose “roughly flat” rates, with payments to Medicare plans projected to rise by a mere 0.09% for the coming year.
This anticipated announcement, expected late Monday, signals a stark contrast to earlier forecasts that predicted rate increases of 4% to 6% for next year. Analysts believe that the proposed modest increase will equate to approximately $700 million, a stark reduction when compared to the 5.06% increase health insurers received this year.
In extended trading, shares of major health insurers took a hit, reflecting investor concerns over the administration’s plans. UnitedHealth Group Inc. saw its stock drop by 8.82% to $322.09, while Humana Inc. and CVS Health Corp. experienced declines of 13.34% (to $227.50) and 11.03% (to $74.62) respectively, according to Benzinga Pro.
Additionally, the Medicare agency is aiming to eliminate certain billing practices that have historically proven lucrative for health insurers, a move that officials say is intended to enhance payment accuracy and ensure fair reimbursements.
As the healthcare market anticipates the formal announcement, stakeholders are closely monitoring the implications these proposed changes could have on the insurance industry and their bottom lines.
